LABinnovatorLABinnovator
COMPANYEVENTSPAST EVENTSPARTNERSCAREERSCONTACT

Intellectual Property Rights
in the Biotech Industry

Designing an IPR strategy to maximise your patent protection in the 21st century.

Date: June 15, 2004
Venue:  Radisson SAS Scandinavia Hotel
City: Copenhagen, Denmark

In the Chair:

Johan Vanhemelrijck
Secretary General
EuropaBio

Hear from your eminent Speaker Panel:

Giampiero De Luca
Chief Intellectual Property Counsel
Serono International

Gerald V. Dahling
Senior Vice President of Global Patents
Aventis (USA)

Lars Kellberg
Vice President Corporate Patents
Novo Nordisk

Annika Kilander
IP Director
Amersham Biosciences

Per Johan Ulfendahl
IP Manager
QUIAtech

Peter Laudrup
Manager Intellectual Property Rights
BioImage

Ingwer Koch
Director and Head of Patent Law
European Patent Office (EPO)

Event Summary:

There is currently a need in many European biotech companies to increase investments in R & D already today to bring more drugs to the global market. A successful IPR strategy in place would make this to a reality. By designing a successful IPR strategy, biopharmaceutical companies are able to maximise patent protection throughout the entire patent life cycle and yield ROI for new scientific and commercial viable discoveries.

An optimal IPR strategy in place accelerates the decision-making process when patent agents choose patent strategy for different products to maximise patent protection. To optimise the success even further, IPR require support from the company’s top executives to visualise the business model and to ensure the entire organisation moves in the right direction. Then it is possible to deliver new innovative medicines much faster to the marketplace. The winners in tomorrow’s biotech world will be the pioneers who recognise IPR as the key to be successful in a technology-driven business environment.

This groundbreaking one day conference will examine future strategic scenarios in the international patent landscape with a focus on the biotech sector. This event provides you with a platform to design a successful IPR strategy with lessons learnt from the pioneers in the patent field.

Key issues:

  • Developing a community patent protection to strengthen the European biotech industry in a global business environment
  • Choosing patent strategies to safeguard your IP investments
  • Maximizing Patent Life Cycle Management in the biotech industry
  • Monitoring your patent portfolio as an out-licensing partner
  • Mastering an IPR regime to extend your freedom to operate

Target audience:

Presidents, Chief Executive Officers, Chief IP Counsel, Vice Presidents, Directors, Heads and Managers of:

  • Corporate Counsel
  • General Counsel
  • Intellectual Property
  • Global Intellectual Property
  • Intellectual Property Rights
  • Corporate Patents
  • Corporate Patents and Trademarks
  • Licensing
  • Legal and Intellectual Property
  • General Patent Counsel
  • Regulatory Affairs
  • Business Development
  • Patent Agents
  • Attorneys / Advisers
  • Partners
  • Venture Capitalists
  • Consultancies
LABinnovator